Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2025-12-31 @ 9:15 PM
Study NCT ID:
NCT01282333
Status:
TERMINATED
Last Update Posted:
2013-07-02
First Post:
2011-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Adult Primary Liver Cancer | View |
| None | Localized Unresectable Adult Primary Liver Cancer | View |
| None | Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | View |
| None | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | View |
| None | Stage III Bladder Cancer | View |
| None | Stage III Pancreatic Cancer | View |
| None | Stage IIIA Non-small Cell Lung Cancer | View |
| None | Stage IIIB Non-small Cell Lung Cancer | View |
| None | Stage IV Bladder Cancer | View |
| None | Stage IV Non-small Cell Lung Cancer | View |
| None | Stage IV Pancreatic Cancer | View |
| None | Transitional Cell Carcinoma of the Bladder | View |
| None | Unresectable Extrahepatic Bile Duct Cancer | View |
| None | Unresectable Gallbladder Cancer | View |
Keywords: